Serum hyaluronate levels predict responsiveness to interferon alpha therapy in patients with chronic hepatitis C
- 30 September 1994
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 229 (1-2) , 191-195
- https://doi.org/10.1016/0009-8981(94)90241-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Assay of serum hyaluronic acid in clinical applicationPublished by Elsevier ,2003
- Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapyGastroenterology, 1993
- HCV genotypes in chronic hepatitis C and response to interferonThe Lancet, 1992
- Hemodynamic and Liver Function Predictors of Serum Hyaluronan in Alcoholic Liver DiseaseHepatology, 1992
- Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcomeJournal of Internal Medicine, 1992
- Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-αHepatology, 1992
- Serum hyaluronate as a marker of hepatic derangement in acute liver damageJournal of Hepatology, 1991
- Interferon-Induced Proteins and the Antiviral StatePublished by Elsevier ,1990
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987
- Increased Serum Levels of Hyaluronate in Liver DiseaseHepatology, 1985